Active Biotech AB (ACTI) Stock Statistics & Valuation Metrics

Active Biotech AB has a market cap or net worth of kr150.78M. The enterprise value is kr15.45B.

Active Biotech AB has 26,360,670 shares outstanding. The number of shares has decreased by -2.65% in one year.

Active Biotech AB’s return on equity (ROE) is -0.67 and return on invested capital (ROIC) is -65.61%.

The current PE Ratio of Active Biotech AB is ―. Active Biotech AB’s PEG ratio is 2.36.

In the last 12 months, Active Biotech AB had revenue of 0.00 and earned -37.30M in profits. Earnings per share was -0.03.

In the last 12 months, operating cash flow was -31.30M and capital expenditures 7.20M, giving a free cash flow of -31.30M billion.

Active Biotech AB pays an annual dividend of ―, resulting in a dividend yield of ―

Active Biotech AB upcoming earnings date is Aug 20, 2026, TBA (Confirmed).

Active Biotech AB as a current ratio of 4.66, with Debt / Equity ratio of 0.21%

In the past 12 months, Active Biotech AB has paid 0.00 in taxes.

Active Biotech AB EV to EBITDA ratio is -170.40, with an EV/FCF ratio of -189.34.

Active Biotech AB has kr53.30M in cash and marketable securities with kr100.00K in debt, giving a net cash position of kr53.20M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Active Biotech AB is ―, which is 11.43% higher than the current price. The consensus rating is ―